Treatment Failure in Patients with Ventilator-Associated Pneumonia

ABSTRACT

Ventilator-associated pneumonia (VAP) is one of the most important infectious diseases in the intensive care unit (ICU). In some series the attributable mortality of VAP may reach 30%, and the adequacy of the initial empirical treatment greatly influences the prognosis. Treatment failure can be anticipated in ~30 to 40% of patients developing pneumonia during mechanical ventilation and this situation is associated with an adverse outcome in terms of morbidity. For these reasons, the lack of response to empirical antibiotic treatment should be recognized early in the course of VAP, and a clear strategy for clarifying the causes of failure should be implemented. Resolution of VAP depends not only on the accuracy of microbial diagnosis but also on comorbidities, the response of the host to the infection, concomitant infections, and the correct clinical diagnosis. Treatment failure can be defined by the pattern of resolution of VAP, which is clearly established in the literature.

KEYWORDS

Ventilator-associated pneumonia - treatment failure - nonresolving pneumonia

REFERENCES

• 1 Niederman M S, Craren D E. ATS Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.  Am J Respir Crit Care Med. 2005;  171 388-416
• 2 Ioanas M, Ferrer M, Cavalcanti M et al.. Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia.  Crit Care Med. 2004;  32 938-945
• 3 Kollef M H, Sherman G, Ward S, Fraser V. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.  Chest. 1999;  115 462-474
• 4 Alvarez-Lerma F. ICU-Acquired Pneumonia Study Group . Modification of empiric antibiotic treatment in patient with pneumonia acquired in the intensive care unit.  Intensive Care Med. 1996;  22 387-394
• 5 Luyt C-E, Guerin V, Combes A et al.. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia.  Am J Respir Crit Care Med. 2005;  171 48-53
• 6 Dupont H, Mentec H, Sollet J P, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia.  Intensive Care Med. 2001;  27 355-362
• 7 Mueller E W, Hanes S D, Croce M A, Wood G C, Boucher B A, Fabian T C. Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality.  J Trauma. 2005;  58 94-101
• 8 Pugin J, Aukenthaler R, Mili N, Janssens J P, Lew P D, Suter P M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid.  Am Rev Respir Dis. 1991;  143 1121-1129
• 9 Luna C M, Blancazo D, Niederman M S et al.. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection store as an early clinical predictor of outcome.  Crit Care Med. 2003;  31 676-682
• 10 Vidaur L, Gualis B, Rodríguez A et al.. Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute respiratory distress syndrome.  Crit Care Med. 2005;  33 1248-1253
• 11 Montravers P, Fagon J Y, Chastre J et al.. Follow-up protected specimen brushes to asses treatment in nosocomial pneumonia.  Am Rev Respir Dis. 1993;  147 38-44
• 12 Dennesen P JW, van der Ven A, Kessels A, Ramsay G, Bonten M. Resolution of infectious parameters alter antimicrobial therapy in patients with ventilator-associated pneumonia.  Am J Respir Crit Care Med. 2001;  163 1371-1375
• 13 Povoa P, Coelho L, Almeida E et al.. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study.  Eur Respir J. 2005;  25 804-812
• 14 Trouillet J L, Chastre J, Vuagnat A et al.. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.  Am J Respir Crit Care Med. 1998;  157 531-539
• 15 Iregui M, Ward S, Sherman G, Fraser V J, Kollef M H. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.  Chest. 2002;  122 262-268
• 16 Garnacho J, Garcia J L, Barrero A, Jiménez F J, Perez C, Ortiz C. Impact of the outcome of adequate empirical antibiotherapy in patients admitted to the ICU for sepsis.  Crit Care Med. 2003;  31 2742-2751
• 17 Rello J, Sa-Borges M, Correa H, Leal S-R, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites.  Am Rev Respir Dis. 1999;  160 608-613
• 18 Petri M G, König J, Moecke H P et al.. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients.  Intensive Care Med. 1997;  23 317-325
• 19 Daubin C, Vincent S, Vabret A et al.. Nosocomial viral ventilator-associated pneumonia in the intensive care unit: a prospective cohort study.  Intensive Care Med. 2005;  31 1116-1122
• 20 Fink M P, Snydman D R, Niederman M S et al.. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastin.  Antimicrob Agents Chemother. 1994;  38 547-557
• 21 Chow J W, Fine M J, Sales D M et al.. Enterobacter bacteremia: clinical factors and emergence of resistance during treatment.  Ann Intern Med. 1991;  115 585-590
• 22 Combes A, Figliolini C, Trouillet J-L et al.. Factors predicting ventilator-associated pneumonia recurrence.  Crit Care Med. 2003;  31 1102-1107
• 23 Meduri G U, Mauldin G L, Wunderik R G et al.. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia.  Chest. 1994;  106 221-235
• 24 Marik P E. Fever in the ICU.  Chest. 2000;  117 855-869
• 25 Bert F, Lambert-Zechovsky N. Sinusitis in mechanically ventilated patients and its role in the pathogenesis of nosocomial pneumonia.  Eur J Clin Microbiol Infect Dis. 1996;  15 533-544
• 26 Rouby J J, Laurent P, Gosnach M et al.. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill.  Am J Respir Crit Care Med. 1994;  150 776-783
• 27 Westergren V, Berg S, Lundgren J. Ultrasonographic bedside evaluation of maxillary sinus disease in mechanically ventilated patients.  Intensive Care Med. 1997;  23 393-398
• 28 Holzapfel L, Chastang C, Demingeon G, Bohe J, Piralla B, Coupry A. A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients: influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia.  Am J Respir Crit Care Med. 1999;  159 695-701
• 29 Winer-Muram H T, Rubin S A, Ellis J V et al.. Pneumonia and ARDS in patients receiving mechanical ventilation: diagnostic accuracy of chest radiography.  Radiology. 1993;  188 479-485
• 30 Fagon J Y, Chastre J, Hance A J, Domart Y, Trouillet J L, Gibert C. Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients.  Chest. 1993;  103 547-553
• 31 Crump J A, Collignon P J. Intravascular catheter-associated infections.  Eur J Clin Microbiol Infect Dis. 2000;  19 1-8
• 32 Richards M J, Edwards J R, Culver D H, Gaynes R P. and the National Nosocomial Infections Surveillance System . Nosocomial infections in medical intensive care units in the United States.  Crit Care Med. 1999;  27 887-892
• 33 Barie P S, Fischer E. Acute acalculous cholecystitis.  J Am Coll Surg. 1995;  180 232-244
• 34 Shields C J, Winter D C, Redmond H P. Lung injury in acute pancreatitis: mechanisms, prevention and therapy.  Curr Opin Crit Care. 2002;  8 158-163
• 35 Kyne L, Hamel M B, Polavaram R, Nelly C P. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile .  Clin Infect Dis. 2002;  34 346-353
• 36 Nakos G, Tsangaris H, Liokatis S, Kitsiouli E, Lekka M E. Ventilator-associated pneumonia and atelectasis: evaluation through bronchoalveolar lavage fluid analysis.  Intensive Care Med. 2003;  29 555-556
• 37 Pistolesi M, Miniati M. Imaging techniques in treatment algorithms of pulmonary embolism.  Eur Respir J. 2002;  35(Suppl) 28-39
• 38 Raño A, Agusti C, Jimenez P et al.. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures.  Thorax. 2001;  56 379-387
• 39 Cordier J F. Organising pneumonia.  Thorax. 2000;  55 318-328
• 40 Delclaux C, Roupie E, Blot F, Brochard L, Lemaire F, Brun-Buisson C. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis.  Am J Respir Crit Care Med. 1997;  156 1092-1098
• 41 Jordan S, Mitchell J A, Quinlan G J, Goldstraw P, Evans T W. The pathogenesis of lung injury following pulmonary resection.  Eur Respir J. 2000;  15 790-799
• 42 Wunderink R G. Ventilator associated-pneumonia: failure to respond to antibiotic therapy.  Clin Chest Med. 1995;  16 173-193
• 43 Mason C M, Nelson S. Normal host defences and impairments associated with the delayed resolution of pneumonia.  Semin Respir Infect. 1992;  7 243-255
• 44 Marshall J, Sweeney D. Microbial infection and the septic response in critical surgical illness: sepsis, not infection, determines outcome.  Arch Surg. 1990;  125 17-22
• 45 Crouch B S, Wunderink R G, Jones C B, Leeper K V. Ventilator-associated pneumonia due to Pseudomonas aeruginosa .  Chest. 1996;  109 1019-1029
• 46 Wu C L, Yang D I, Wang N Y, Kuo H T, Chen P Z. Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure.  Chest. 2002;  122 662-668
• 47 O’Brien J D, Ettinger N A, Shevlin D, Kollef M H. Safety and yield of transbronchial biopsy in mechanically ventilated patients.  Crit Care Med. 1997;  25 440-446
• 48 Bulpa P A, Dive A M, Mertens L et al.. Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients.  Eur Respir J. 2003;  21 489-494